Sign in

CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company

CytoDyn Inc.

Sign in to watch
Ticker
CYDY
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
May 31
Incorporated
DE
Entity type
operating
EIN
753056237
Phone
360-980-8524
Business address
1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
Former names
CYTODYN INC, REXRAY CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-22 Mulholland Michael D. Chief Financial Officer Sale −245,704 $5.49 $1.3M 750,178
2020-12-22 Mulholland Michael D. Chief Financial Officer Sale −453,997 $6.61 $3.0M 296,181
2020-12-22 Mulholland Michael D. Chief Financial Officer Sale −12,100 $7.00 $85K 284,081
2020-12-21 Mulholland Michael D. Chief Financial Officer Sale −585,797 $5.58 $3.3M 284,081
2020-12-21 Mulholland Michael D. Chief Financial Officer Sale −589,797 $5.58 $3.3M 284,081
2020-12-18 Mulholland Michael D. Chief Financial Officer Sale −487,002 $4.95 $2.4M 284,081
2020-12-18 Mulholland Michael D. Chief Financial Officer Sale −487,002 $4.95 $2.4M 284,081
2020-12-17 Mulholland Michael D. Chief Financial Officer Sale −32,000 $4.55 $146K 284,081
2020-12-17 Mulholland Michael D. Chief Financial Officer Sale −32,000 $4.55 $146K 284,081
2020-05-04 Pourhassan Nader President & CEO Sale −1,201,652 $2.79 $3.4M 908,343
2020-05-01 Kelly Scott A. Chairman & CMO Sale −1,200,000 $3.26 $3.9M 1,557,718
2020-05-01 Kelly Scott A. Chief Medical Officer Sale −1,200,000 $3.26 $3.9M 1,557,718
2020-05-01 Pourhassan Nader President & CEO Sale −1,399,685 $3.26 $4.6M 2,079,062
2020-04-30 Pourhassan Nader President & CEO Sale −2,219,837 $3.53 $7.8M 3,478,747

Page 1 of 1 · 14 trades